Testing effectiveness (Phase 2)UnknownNCT01228396
What this trial is testing
AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis
Who this might be right for
Secondary Progressive Multiple Sclerosis
Daval International Limited 20